EPROSARTAN
- CAS No.
- 133040-01-4
- Chemical Name:
- EPROSARTAN
- Synonyms
- Teveten;Navixen;CS-1951;EPROSARTAN;SKB 108566;SKF-108566J;SKF-108566);Eprosartan-d4;prop-1-en-1-yl);13C6]-Eprosartan
- CBNumber:
- CB0135346
- Molecular Formula:
- C23H24N2O4S
- Molecular Weight:
- 424.51
- MDL Number:
- MFCD00897872
- MOL File:
- 133040-01-4.mol
- MSDS File:
- SDS
Melting point | 250-253°C |
---|---|
storage temp. | Sealed in dry,2-8°C |
solubility | Dichloromethane (Slightly), Methanol (Slightly) |
form | Solid |
color | Pale Yellow to Light Yellow |
CAS DataBase Reference | 133040-01-4 |
FDA UNII | 2KH13Z0S0Y |
ATC code | C09CA02 |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H315-H319 |
Precautionary statements | P305+P351+P338 |
EPROSARTAN price More Price(17)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
TRC | E590100 | Eprosartan | 133040-01-4 | 10mg | $70 | 2021-12-16 | Buy |
Matrix Scientific | 094012 | Eprosartan 95+% | 133040-01-4 | 1g | $227 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | API0000548 | EPROSARTAN 95.00% | 133040-01-4 | 1G | $284.55 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | RDL0006807 | EPROSARTAN-D4 95.00% | 133040-01-4 | 5MG | $501.55 | 2021-12-16 | Buy |
Medical Isotopes, Inc. | D33956 | Eprosartan-d6 | 133040-01-4 | 1mg | $600 | 2021-12-16 | Buy |
EPROSARTAN Chemical Properties,Uses,Production
Description
Teveten was launched in Germany for the treatment of hypertension. There are several ways in which it has been prepared, the shortest of which is four steps; beginning with displacement of 2-butyl-4-chloroimidazole-5-carboxaldehyde with methyl 4-(bromomethyl)benzoate. Teveten is an angiotensin Ⅱ antagonist selective for the AT, subtype receptor. It is a potent, highly selective, competitve antagonist with no agonist activity. Duration of action is similar to Enalapril (greater than 12 hr) but Teveten had a faster onset. While it is orally active, it rapidly dissociates from the receptor. This is contrary to its prolonged duration of action, which presumably results from slow removal from compartments within tissue, cells or matrix around the AT, receptor. It is not bound by BSA.
Chemical Properties
Light-Yellow Solid
Originator
SmithKline Beecham (UK)
Uses
Prototype of the imidazoleacrylic acid angiotensin II receptor antagonists. Antihypertensive
Uses
Eprosartan is a prototype of the imidazoleacrylic acid angiotensin II receptor antagonists. Eprosartan is an antihypertensive.
Uses
Eprosartan (E590100) impurity.
Definition
ChEBI: A member of the class of imidazoles and thiophenes that is an angiotensin II receptor antagonist used for the treatment of high blood pressure.
brand name
Teveten
Clinical Use
Angiotensin-II antagonistHypertension
Drug interactions
Potentially hazardous interactions with other drugs Anaesthetics: enhanced hypotensive effect.Analgesics: antagonism of hypotensive effect and increased risk of renal impairment with NSAIDs; hyperkalaemia with ketorolac and other NSAIDs.Antihypertensives: increased risk of hyperkalaemia hypotension and renal impairment with ACE inhibitors and aliskiren.Ciclosporin: increased risk of hyperkalaemia and nephrotoxicity.Diuretics: enhanced hypotensive effect; hyperkalaemia with potassium-sparing diuretics.Epoetin: increased risk of hyperkalaemia; antagonism of hypotensive effect.Lithium: reduced excretion, possibility of enhanced lithium toxicity.Potassium salts: increased risk of hyperkalaemia.Tacrolimus: increased risk of hyperkalaemia and nephrotoxicity.
Metabolism
Following oral and intravenous dosing with [14C] eprosartan in human subjects, eprosartan was the only drug-related compound found in the plasma and faeces. In the urine, approximately 20% of the radioactivity excreted was an acyl glucuronide of eprosartan with the remaining 80% being unchanged eprosartanEprosartan is eliminated by both biliary and renal excretion. Following intravenous [14C] eprosartan, about 61% of radioactivity is recovered in the faeces and about 37% in the urine. Following an oral dose of [14C] eprosartan, about 90% of radioactivity is recovered in the faeces and about 7% in the urine.
![133040-03-6](/StructureFile/ChemBookStructure22/GIF/CB3507489.gif)
![143468-96-6](/CAS/GIF/143468-96-6.gif)
![133040-01-4](/CAS/GIF/133040-01-4.gif)
EPROSARTAN Preparation Products And Raw materials
Raw materials
1of3
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Capot Chemical Co.,Ltd. | 571-85586718 +8613336195806 | sales@capotchem.com | China | 29798 | 60 |
Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21668 | 55 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49391 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | laboratory@coreychem.com | China | 30250 | 58 |
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 | eric@witopchemical.com | China | 23556 | 58 |
Shaanxi Dideu Medichem Co. Ltd | +86-029-89586680 +86-18192503167 | 1026@dideu.com | China | 8853 | 58 |
AFINE CHEMICALS LIMITED | +86-0571-85134551 | info@afinechem.com | China | 15395 | 58 |
Hefei TNJ Chemical Industry Co.,Ltd. | 0551-65418684 +8618949823763 | sales@tnjchem.com | China | 25363 | 58 |
GIHI CHEMICALS CO.,LIMITED | +8618058761490 | info@gihichemicals.com | China | 50000 | 58 |
View Lastest Price from EPROSARTAN manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2020-05-10 | Eprosartan
133040-01-4
|
US $0.00-0.00 / Kg | 1KG | 99.0% | 500 MT | Shaanxi Dideu Medichem Co. Ltd |
-
- Eprosartan
133040-01-4
- US $0.00-0.00 / Kg
- 99.0%
- Shaanxi Dideu Medichem Co. Ltd
133040-01-4(EPROSARTAN)Related Search:
1of4